We are live on ! Find out more
BLFS icon

BioLife Solutions

188 hedge funds and large institutions have $1.12B invested in BioLife Solutions in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

4% more funds holding

Funds holding: 180188 (+8)

1.56% more ownership

Funds ownership: 100.89%102.45% (+1.6%)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

7% less capital invested

Capital invested by funds: $1.21B → $1.12B (-$90.3M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

98% less call options, than puts

Call options by funds: $65K | Put options by funds: $4.17M

Holders
188
Holders Change
+8
Holders Change %
+4.44%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
28
Increased
60
Reduced
62
Closed
18
Calls
$65K
Puts
$4.17M
Net Calls
-$4.1M
Net Calls Change
-$4.04M

BLFS Hedge Fund Activity: Q1 2025 in Review

188 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2025, worth a combined $1.12B — down 7.4% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BLFS positions and 18 closed out — a net gain of 10 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $35.5M. The largest seller was Millennium Management, cutting an estimated $19.9M.

  • 188 institutional investors held BioLife Solutions (BLFS) as of Q1 2025, up from 180 in Q4 2024.
  • Funds reported $1.12B of BioLife Solutions stock for Q1 2025, down 7.4% quarter-over-quarter.
  • 28 funds opened new BioLife Solutions positions in Q1 2025 and 18 closed out, a net change of +10 holders.
  • The largest BioLife Solutions buyer in Q1 2025 was T. Rowe Price Investment Management, an estimated $35.5M added.
  • The largest BioLife Solutions seller in Q1 2025 was Millennium Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q1 2025.